Project Details
Description
A 12-Week, Phase 2 Open-Label, Sequential Dose Cohort Study to Evaluate the Safety, Efficacy, And Pharmacokinetics of CRN04894 Treatment in Participants with Congenital Adrenal Hyperplasia
| Status | Active |
|---|---|
| Effective start/end date | 6/2/23 → 6/30/33 |
Funding
- CRINETICS PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.